Motherboard

BeautyFarm Med, the largest provider of traditional beauty services in China Successfully Listed on the Main Board of SEHK

Retrieved on: 
Tuesday, January 17, 2023

The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price.

Key Points: 
  • The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price.
  • BeautyFarm Med is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China with a market share of 0.2% and 0.6%, respectively, as measured by revenue in 2021 and according to Frost & Sullivan.
  • The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology.
  • The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle.

BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share

Retrieved on: 
Friday, January 13, 2023

The Offer Price is HK$19.32 per share.

Key Points: 
  • The Offer Price is HK$19.32 per share.
  • The Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have been very significantly oversubscribed.
  • The Offer Shares initially offered under the International Offering have been moderately oversubscribed, representing approximately 4.7 times of the total number of 36,482,500 International Offer Shares initially available for subscription under the International Offering.
  • The outstanding share oversubscription shows the trust and support of global investors for the Company's business development and lays a firm ground for the Company's long-term growth.

SinoHytec Successfully Listed on the Main Board of HKEX

Retrieved on: 
Thursday, January 12, 2023

SinoHytec adheres to the R&D principles of "Advance Research", "Continuous Development" and "In-depth Promotion".

Key Points: 
  • SinoHytec adheres to the R&D principles of "Advance Research", "Continuous Development" and "In-depth Promotion".
  • In addition, the Company plans to develop and manufacture membrane electrodes, another major fuel cell stack component, through its main associate company, Shanghai Maximfuelcell Technology Co., Ltd.
  • Mr. Zhang Guoqiang, Chairman, Executive Director and General Manager of SinoHytec said: "Today, SinoHytec is officially listed on the Main Board of the Hong Kong Stock Exchange, which is an important milestone in the Company's development and marks the entry of SinoHytec into the international capital market.
  • We would like to express our gratitude to our investors for their trust and support of SinoHytec.

Kingsoft Cloud's Dual Primary Hong Kong Listing: Resilience Rooted in Technology-based Business, High-quality Development Expected from Improving Profitability

Retrieved on: 
Friday, December 30, 2022

In combination with in-depth understanding of strategically selected verticals, Kingsoft Cloud accomplished fast growth in both business scale and financials.

Key Points: 
  • In combination with in-depth understanding of strategically selected verticals, Kingsoft Cloud accomplished fast growth in both business scale and financials.
  • Kingsoft Cloud made proactive adjustments, allocated resources in favor of more profitable products and projects to achieve improved sustainability, profitability and operating cash flow.
  • Kingsoft Cloud has always been strongly supported by the strategic shareholders Xiaomi and Kingsoft Group.
  • He Haijian, CFO of Kingsoft Cloud, also said, "Primary listing in Hong Kong will broaden our investor base, facilitate our participation in Hong Kong Stock Connect, and open up investment cooperation channels to more Chinese mainland investors.

Beauty Farm Medical and Health Industry Inc. Announces Proposed Listing on the Main Board of SEHK, Offer price at HK$19.32 per share

Retrieved on: 
Friday, December 30, 2022

The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology.

Key Points: 
  • The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology.
  • As of June 30, 2022, the overall service network of Beauty Farm comprised 352 stores, including 177 direct stores and 175 franchised stores.
  • Constant evolution of business model in response to market demand, offering clients overall beauty and health management services
    As the leading chain brand in China's beauty and health management service industry, Beauty Farm has provided traditional beauty services to clients for nearly three decades.
  • Beauty Farm Medical and Health Industry Inc.
    Beauty Farm Medical and Health Industry Inc. ("Beauty Farm" or "Company", stock code: 2373) is a leading player in China's beauty and health management service industry, which has large and loyal client base, extensive network with expansion efficiency, diversified services and product offerings as well as strong brand awareness.

SinoHytec Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange, Offer Price Between HK$60 and HK$76 per H Share, Raise up to HK$1,540.7 million

Retrieved on: 
Thursday, December 29, 2022

The Hong Kong Public Offering will commence at 9 a.m., December 29, 2022 (Thursday), and close at 12:00 noon on January 5, 2023 (Thursday).

Key Points: 
  • The Hong Kong Public Offering will commence at 9 a.m., December 29, 2022 (Thursday), and close at 12:00 noon on January 5, 2023 (Thursday).
  • Dealings in the shares of SinoHytec on the Main Board of the Hong Kong Stock Exchange is expected to commence on January 12, 2023 (Thursday), with the stock code 2402 and in board lots of 50 Offer Shares each.
  • Established in 2012, the company is a pioneer in the R&D and commercialization of fuel cell systems in China and started batch production in 2016.
  • As of December 20, 2022, the company's fuel cell systems have powered over 2,800 fuel cell vehicles on the road in China.

Shares of Major Global Medical Device Manufacturer OrbusNeich Medical Group Commence Trading on the Main Board of The Stock Exchange of Hong Kong

Retrieved on: 
Friday, December 23, 2022

HONG KONG, Dec 23, 2022 - (ACN Newswire) - Shares of OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, today commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX"), under the stock code 6929.

Key Points: 
  • HONG KONG, Dec 23, 2022 - (ACN Newswire) - Shares of OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, today commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX"), under the stock code 6929.
  • Mr. Teddy Chien, Chairman Emeritus and Founder (right) and Mr. David Chien, Chairman, Executive Director, Chief Executive Officer (left), together strike the ceremonial gong, marking the Group's listing on the Main Board of HKEX
    OrbusNeich makes a generous donation of HK$3,000,000 to HKEX Foundation to secure the auspicious stock code number "6929".
  • Mr. David Chien, Chairman, Executive Director, Chief Executive Officer (right) presents the cheque to HKEX
    (From left to right): John Chow,Executive Director and Head of Business Development; Jason Chen, Executive Director, Chief Financial Officer and Company Secretary; Gloria Tam, Independent Non-executive Director; Denise Lau, Executive Director and Chief Operating Officer; Teddy Chien, Chairman Emeritus and Founder; David Chien, Chairman, Executive Director and Chief Executive Officer; George Lau, Independent Non-executive Director; Angus Chan, Independent Non-executive Director

Kingsoft Cloud Announces Results of Extraordinary General Meeting Following Proposed Dual Primary Listing on Hong Kong Stock Exchange and New Board Appointment

Retrieved on: 
Thursday, December 29, 2022

Earlier on December 23, 2022, the Company announced the proposed dual primary listing of its ordinary shares, par value US$0.001 per share by way of introduction on the Main Board of The Stock Exchange of Hong Kong Limited.

Key Points: 
  • Earlier on December 23, 2022, the Company announced the proposed dual primary listing of its ordinary shares, par value US$0.001 per share by way of introduction on the Main Board of The Stock Exchange of Hong Kong Limited.
  • He, in his new roles, will be a valuable asset for the Board and drive the Company’s long-term growth.
  • Statements that are not historical facts, including but not limited to statements about Kingsoft Cloud’s beliefs and expectations, are forward-looking statements.
  • Further information regarding these and other risks is included in Kingsoft Cloud’s filings with the SEC.

KANZHUN LIMITED Successfully Listed on the Main Board of The Stock Exchange of Hong Kong

Retrieved on: 
Thursday, December 22, 2022

BEIJING, Dec. 22, 2022 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ), a leading online recruitment platform in China, today announced that it has successfully listed, by way of introduction, its Class A ordinary shares (the “Shares”) on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKEX”).

Key Points: 
  • BEIJING, Dec. 22, 2022 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ), a leading online recruitment platform in China, today announced that it has successfully listed, by way of introduction, its Class A ordinary shares (the “Shares”) on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKEX”).
  • The Shares are traded on the Main Board of the HKEX under the stock code “2076” in board lots of 100 Shares, and the stock short name is “BOSS ZHIPIN-W”.
  • The Company’s American depositary shares (the “ADSs”), each representing two Shares, remain primarily listed and traded on the Nasdaq Global Select Market (the “Nasdaq”).
  • The Shares listed on the Main Board of the HKEX are fully fungible with the ADSs listed on the Nasdaq.

Futu Announces Proposed Dual Primary Listing on The Stock Exchange of Hong Kong Limited

Retrieved on: 
Thursday, December 22, 2022

HONG KONG, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced the proposed dual primary listing of its Class A ordinary shares, par value US$0.00001 per share (the “Shares”) by way of introduction on the Main Board of The Stock Exchange of Hong Kong Limited (the “SEHK”).

Key Points: 
  • HONG KONG, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced the proposed dual primary listing of its Class A ordinary shares, par value US$0.00001 per share (the “Shares”) by way of introduction on the Main Board of The Stock Exchange of Hong Kong Limited (the “SEHK”).
  • The Company has received a letter of in-principle approval of its listing application from the SEHK on December 21, 2022 (Hong Kong Time) for the dual primary listing of the Shares on the Main Board of the SEHK.
  • The listing document relating to the proposed dual primary listing of the Shares by way of introduction on the Main Board of the SEHK (the “Listing Document”) has been published on the website of the SEHK on December 22, 2022 (Hong Kong Time).
  • With respect to the proposed dual primary listing on the Main Board of the SEHK, Goldman Sachs (Asia) L.L.C.